Natixis Investment Managers International’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,397
Closed -$1.33M 584
2018
Q3
$1.33M Buy
10,397
+3,765
+57% +$448K 0.06% 280
2018
Q2
$718K Buy
+6,632
New +$722K 0.04% 344
2017
Q1
Sell
-4,551
Closed -$456K 456
2016
Q4
$456K Buy
+4,551
New +$488K 0.04% 258
2016
Q1
Sell
-3,480
Closed -$347K 417
2015
Q4
$347K Buy
+3,480
New +$340K 0.05% 212
2015
Q3
Sell
-3,775
Closed -$400K 458
2015
Q2
$400K Buy
3,775
+120
+3% +$13.3K 0.05% 247
2015
Q1
$417K Sell
3,655
-582
-14% -$66.4K 0.05% 208
2014
Q4
$467K Buy
+4,237
New +$447K 0.06% 196

Other funds holding ZBH

Natixis Investment Managers International's ZBH Position: Q4 2018 in Review

Natixis Investment Managers International sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 10,397 shares — an estimated $1.33M sold.

Natixis Investment Managers International first reported a position in ZBH in Q4 2014 and held it in 7 quarters. The position peaked at $1.33M in Q3 2018. 872 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

  • Natixis Investment Managers International reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 10,397 Zimmer Biomet shares in Q4 2018, an estimated $1.33M.
  • Natixis Investment Managers International first reported a position in Zimmer Biomet in Q4 2014 and held it in 7 quarters.
  • Natixis Investment Managers International's Zimmer Biomet position peaked at $1.33M in Q3 2018.
  • 872 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Natixis Investment Managers International's 13F filing for Q4 2018, filed 14 Feb 2019.